These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 38186574)

  • 21. The prognostic value of immune escape-related genes in lung adenocarcinoma.
    Jia HR; Li WC; Wu L
    Transl Cancer Res; 2024 Jun; 13(6):2647-2661. PubMed ID: 38988926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine-learning developed an iron, copper, and sulfur-metabolism associated signature predicts lung adenocarcinoma prognosis and therapy response.
    Zhang L; Zhang X; Guan M; Zeng J; Yu F; Lai F
    Respir Res; 2024 May; 25(1):206. PubMed ID: 38745285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disulfidptosis-related lncRNAs signature predicting prognosis and immunotherapy effect in lung adenocarcinoma.
    Hong S; Zhang Y; Wang D; Wang H; Zhang H; Jiang J; Chen L
    Aging (Albany NY); 2024 Jun; 16(11):9972-9989. PubMed ID: 38862217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
    Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
    Front Immunol; 2022; 13():783495. PubMed ID: 35222371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
    Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
    Front Genet; 2022; 13():1017866. PubMed ID: 36699466
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of Cancer Stem Cell-related Gene by Single-cell and Machine Learning Predicts Immune Status, Chemotherapy Drug, and Prognosis in Lung Adenocarcinoma.
    Yang C; Zhang J; Xie J; Li L; Zhao X; Liu J; Wang X
    Curr Stem Cell Res Ther; 2024; 19(5):767-780. PubMed ID: 37455453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid metabolism-related gene prognostic index (LMRGPI) reveals distinct prognosis and treatment patterns for patients with early-stage pulmonary adenocarcinoma.
    Jiang A; Chen X; Zheng H; Liu N; Ding Q; Li Y; Fan C; Fu X; Liang X; Tian T; Ruan Z; Yao Y
    Int J Med Sci; 2022; 19(4):711-728. PubMed ID: 35582412
    [No Abstract]   [Full Text] [Related]  

  • 30. Integrating multi-omics and machine learning survival frameworks to build a prognostic model based on immune function and cell death patterns in a lung adenocarcinoma cohort.
    Xie Y; Chen H; Tian M; Wang Z; Wang L; Zhang J; Wang X; Lian C
    Front Immunol; 2024; 15():1460547. PubMed ID: 39346927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma.
    Luo Y; Zhang S; Xie H; Su Q; He S; Lei Z
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):51-61. PubMed ID: 38279482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma.
    Zhang L; Zhang X; Guan M; Zeng J; Yu F; Lai F
    Inflamm Res; 2024 May; 73(5):841-866. PubMed ID: 38507067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of a Machine Learning Prognostic Model of m5C Related immune Genes in Lung Adenocarcinoma.
    Cao X; Ji Y; Li J; Liu Z; Chen C
    Cancer Control; 2024; 31():10732748241237414. PubMed ID: 38537151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective poly adenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research.
    Wu L; Zhong Y; Yu X; Wu D; Xu P; Lv L; Ruan X; Liu Q; Feng Y; Liu J; Li X
    Anticancer Drugs; 2022 Oct; 33(9):943-959. PubMed ID: 35946526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of genomic instability-related genes predicts survival and therapeutic response in lung adenocarcinoma.
    Li S; Wang W; Yu H; Zhang S; Bi W; Sun S; Hong B; Fang Z; Chen X
    BMC Cancer; 2023 Nov; 23(1):1115. PubMed ID: 37974107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intercellular Communication-Related Molecular Subtypes and a Gene Signature Identified by the Single-Cell RNA Sequencing Combined with a Transcriptomic Analysis.
    Guan P; Cai W; Wu K; Jiang F; Wu J; Zhai X; Zeng M
    Dis Markers; 2022; 2022():6837849. PubMed ID: 35620271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis.
    Jiang Y; Hammad B; Huang H; Zhang C; Xiao B; Liu L; Liu Q; Liang H; Zhao Z; Gao Y
    Transl Lung Cancer Res; 2024 Jun; 13(6):1277-1295. PubMed ID: 38973963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma.
    Song C; Pan S; Li D; Hao B; Lu Z; Lai K; Li N; Geng Q
    BMC Med Genomics; 2022 Sep; 15(1):198. PubMed ID: 36117156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell sequencing analysis and transcriptome analysis constructed the macrophage related gene-related signature in lung adenocarcinoma and verified by an independent cohort.
    Li R; Tong R; Zhang Z; Deng M; Wang T; Hou G
    Genomics; 2022 Nov; 114(6):110520. PubMed ID: 36372305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a combined hypoxia and lactate metabolism prognostic signature in lung adenocarcinoma.
    Sun J; Jiang R; Hou L; Wang L; Li M; Dong H; Dong N; Lin Y; Zhu Z; Zhang G; Zhang Y
    BMC Pulm Med; 2024 Jul; 24(1):323. PubMed ID: 38965505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.